Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephen Tucker, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00581425
First received: December 21, 2007
Last updated: January 23, 2013
Last verified: January 2013

December 21, 2007
January 23, 2013
December 2007
September 2011   (final data collection date for primary outcome measure)
resolution of basal cell carcinoma [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00581425 on ClinicalTrials.gov Archive Site
resolution of basal cell carcinoma at a lower cost and less inflammation. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
resolution of basal cell carcinoma [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp

A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.

Not Provided
Interventional
Phase 4
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Basal Cell Carcinoma
Biological: Imiquimod and Interferon alpha
Imiquimod first two weeks and last two weeks. Interferon middle five weeks.
Experimental: Treated
Intervention: Biological: Imiquimod and Interferon alpha
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
49
September 2011
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Nodular or superficial basal cell carcinoma on the skin excluding scalp or face

Exclusion Criteria:

  • Pregnancy
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00581425
HSC-MS-06-0478, OSP-24412
Yes
Stephen Tucker, The University of Texas Health Science Center, Houston
The University of Texas Health Science Center, Houston
Not Provided
Principal Investigator: Stephen B Tucker, M.D. University of Texas Health Science Center of Houston Dermatology Clinic
The University of Texas Health Science Center, Houston
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP